Risultati della ricerca - Joseph Brandwein

Raffina i risultati
  1. 1
    Outcomes and quality of care in acute myeloid leukemia over 40 years

    Outcomes and quality of care in acute myeloid leukemia over 40 years di Shabbir M.H. Alibhai, Marc Leach, Mark D. Minden, Joseph Brandwein

    Pubblicazione 2009
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  2. 2
    Therapy‐related acute lymphoblastic leukemia is more frequent than previously recognized and has a poor prognosis

    Therapy‐related acute lymphoblastic leukemia is more frequent than previously recognized and has a poor prognosis di Amal Abdulwahab, Jenna Sykes, Suzanne Kamel‐Reid, Hong Chang, Joseph Brandwein

    Pubblicazione 2011
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    A Real-World Evaluation of Frontline Treatment for Acute Myeloid Leukemia with Azacitidine plus Venetoclax

    A Real-World Evaluation of Frontline Treatment for Acute Myeloid Leukemia with Azacitidine plus Venetoclax di Joseph Brandwein, David Page, Elena Liew, Mark Hnatiuk, Lauren Bolster, Marlene Hamilton, Daniel Sawler, Peng Wang

    Pubblicazione 2025
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Symptom burden and supportive care in patients with acute leukemia

    Symptom burden and supportive care in patients with acute leukemia di Camilla Zimmermann, Dora Yuen, Ashley Mischitelle, Mark D. Minden, Joseph Brandwein, Aaron D. Schimmer, Lucia Gagliese, Christopher Lo, Anne Rydall, Gary Rodin

    Pubblicazione 2013
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    A clinical trial of supervised exercise for adult inpatients with acute myeloid leukemia (AML) undergoing induction chemotherapy

    A clinical trial of supervised exercise for adult inpatients with acute myeloid leukemia (AML) undergoing induction chemotherapy di Shabbir M.H. Alibhai, Sara O’Neill, Karla Fisher-Schlombs, Henriette Breunis, Joseph Brandwein, Narhari Timilshina, George Tomlinson, Heidi D. Klepin, S. Nicole Culos‐Reed

    Pubblicazione 2012
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    A multicenter pilot‐randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation

    A multicenter pilot‐randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute le... di Kathryn E. Webert, Richard J. Cook, Stephen Couban, Julie Carruthers, Ker‐Ai Lee, Morris A. Blajchman, Jeffrey H. Lipton, Joseph Brandwein, Nancy M. Heddle

    Pubblicazione 2007
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Traumatic stress in acute leukemia

    Traumatic stress in acute leukemia di Gary Rodin, Dora Yuen, Ashley Mischitelle, Mark D. Minden, Joseph Brandwein, Aaron D. Schimmer, Charles R. Marmar, Lucia Gagliese, Christopher Lo, Anne Rydall, Camilla Zimmermann

    Pubblicazione 2011
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Expanded antigen-experienced CD160<sup>+</sup>CD8<sup>+</sup>effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia

    Expanded antigen-experienced CD160<sup>+</sup>CD8<sup>+</sup>effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia di Najmeh Bozorgmehr, Isobel Okoye, Olaide Oyegbami, Lai Xu, Amélie Fontaine, Nanette Cox-Kennett, Loree Larratt, Mark Hnatiuk, Andrei Fagarasanu, Joseph Brandwein, Anthea Peters, Shokrollah Elahi

    Pubblicazione 2021
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia

    A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia di Nancy M. Heddle, Richard J. Cook, Alan Tinmouth, C. Tom Kouroukis, Tor Hervig, Ellen Klapper, Joseph Brandwein, Zbigniew M. Szczepiorkowski, James P. AuBuchon, Rebecca Barty, Ker‐Ai Lee

    Pubblicazione 2008
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasms

    Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasms di Theodore A. Kennedy, Eshetu G. Atenafu, Hans A. Messner, Kenneth J. Craddock, Joseph Brandwein, Jeffrey H. Lipton, Mark D. Minden, Aaron D. Schimmer, Andre C. Schuh, Karen Yee, Vikas Gupta

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Treatment of adults with BCR‐ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen

    Treatment of adults with BCR‐ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen di John M. Storring, Mark D. Minden, Susan Kao, Vikas Gupta, Andre C. Schuh, Aaron D. Schimmer, Karen Yee, Suzanne Kamel‐Reid, Hong Chang, Jeffrey H. Lipton, Hans A. Messner, Wei Xu, Joseph Brandwein

    Pubblicazione 2009
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Fate of Patients with Newly Diagnosed Acute Myeloid Leukemia Who Fail Primary Induction Therapy

    Fate of Patients with Newly Diagnosed Acute Myeloid Leukemia Who Fail Primary Induction Therapy di Megan Othus, Frederick R. Appelbaum, Stephen H. Petersdorf, Kenneth J. Kopecky, Marilyn L. Slovak, Thomas J. Nevill, Joseph Brandwein, Richard A. Larson, Patrick J. Stiff, Roland B. Walter, Martin S. Tallman, Leif Stenke, Harry P. Erba

    Pubblicazione 2014
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia

    A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia di Gregory A. Reed, Gary J. Schiller, Suman Kambhampati, Martin S. Tallman, Dan Douer, Mark D. Minden, Karen Yee, Vikas Gupta, Joseph Brandwein, Yulia Jitkova, Marcela Gronda, Rose Hurren, Aisha Shamas‐Din, Andre C. Schuh, Aaron D. Schimmer

    Pubblicazione 2016
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia

    Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia di Kristie A. Blum, Anjani Advani, Louis A. Fernandez, Richard van der Jagt, Joseph Brandwein, Suman Kambhampati, Jeannine Kassis, Melanie E. Davis, Claire Bonfils, Marja Dubay, Julie Dumouchel, Michel Drouin, David Lucas, Robert E. Martell, John C. Byrd

    Pubblicazione 2009
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia

    A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia di Stephen H. Petersdorf, Kenneth J. Kopecky, Marilyn L. Slovak, Cheryl L. Willman, Thomas J. Nevill, Joseph Brandwein, Richard A. Larson, Harry P. Erba, Patrick J. Stiff, Robert K. Stuart, Roland B. Walter, Martin S. Tallman, Leif Stenke, Frederick R. Appelbaum

    Pubblicazione 2013
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Single-Agent Lenalidomide in the Treatment of Previously Untreated Chronic Lymphocytic Leukemia

    Single-Agent Lenalidomide in the Treatment of Previously Untreated Chronic Lymphocytic Leukemia di Christine I. Chen, P. Leif Bergsagel, Harminder Paul, Wei Xu, Anthea Lau, Nimisha Dave, Vishal Kukreti, Ellen Wei, Chungyee Leung-Hagesteijn, Zhihua Li, Joseph Brandwein, Mariela Pantoja, James B. Johnston, Spencer B. Gibson, Tiffany Hernandez, David Spaner, Suzanne Trudel

    Pubblicazione 2010
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy

    Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy di Hartmut Döhner, Michael Lübbert, Walter Fiedler, L Fouillard, A.K. Haaland, Joseph Brandwein, Stéphane Leprêtre, Oumédaly Reman, Pascal Turlure, Oliver G. Ottmann, Carsten Müller‐Tidow, Alwin Krämer, Emmanuel Raffoux, Konstanze Döhner, Richard F. Schlenk, Florian Voß, Tillmann Taube, Holger Fritsch, Johan Maertens

    Pubblicazione 2014
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies

    A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies di Aaron D. Schimmer, Susan O’Brien, Hagop M. Kantarjian, Joseph Brandwein, Bruce D. Cheson, Mark D. Minden, Karen Yee, Farhad Ravandi, Francis J. Giles, Andre C. Schuh, Vikas Gupta, Michael Andreeff, Charles Koller, Hong Chang, Suzanne Kamel‐Reid, Mark S. Berger, Jean Viallet, Gautam Borthakur

    Pubblicazione 2008
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Phase I/II Trial of AEG35156 X-Linked Inhibitor of Apoptosis Protein Antisense Oligonucleotide Combined With Idarubicin and Cytarabine in Patients With Relapsed or Primary Refractory Acute Myeloid Leukemia

    Phase I/II Trial of AEG35156 X-Linked Inhibitor of Apoptosis Protein Antisense Oligonucleotide Combined With Idarubicin and Cytarabine in Patients With Relapsed or Primary Refracto... di Aaron D. Schimmer, Elihu H. Estey, Gautam Borthakur, Bing Z. Carter, Gary J. Schiller, Martin S. Tallman, Jessica K. Altman, Judith E. Karp, Jeannine Kassis, David W. Hedley, Joseph Brandwein, Wei Xu, Duncan H. Mak, Eric C. LaCasse, Christine Jacob, Stephen J. Morris, Jacques Jolivet, Michael Andreeff

    Pubblicazione 2009
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia

    Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refrac... di Eric J. Feldman, Joseph Brandwein, Richard M. Stone, Matt Kalaycio, Joseph O. Moore, Julie O’Connor, Nancy Wedel, Gail J. Roboz, Carole B. Miller, Raj Chopra, Joseph C. Jurcic, Randy A. Brown, W. Christopher Ehmann, Philip Schulman, Stanley R. Frankel, Daniel De Angelo, David A. Scheinberg

    Pubblicazione 2005
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: